Details of the Drug
General Information of Drug (ID: DMHYQ3Z)
| Drug Name |
3-benzyl-5-methylbenzo[d]oxazol-2(3H)-one
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
3-Benzyl-5-methyl-3H-benzooxazol-2-one; CHEMBL523238; 3-benzyl-5-methylbenzo[d]oxazol-2(3H)-one; F1633-0044; 107235-17-6; AC1LLOHB; BAS 07089306; MLS001205717; SCHEMBL10874258; MolPort-000-473-697; ZINC806272; HMS2816L07; BDBM50265523; ZINC 00806272; AKOS000649124; MCULE-9514588723; CCG-142613; SMR000523953; 3-benzyl-5-methyl-1,3-benzoxazol-2-one; 5-methyl-3-benzyl-3-hydrobenzoxazol-2-one
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 239.27 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 3.2 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||


